EDGAR·FLOW

Royalty Pharma plc — Form 4

Filed November 18, 2026 · analyzed by the Insider Agent
4 ▼ Likely negative significance 44/100
What the filing says
EVP, Research & Investments Urist Marshall (RPRX) sold 25K shares (~$1.7M) on the open market (17% of holdings). Open-market sale — often routine.
Why this rating

Open-market sale — often routine.

View original filing on SEC.gov ↗ RPRX · stock on Yahoo Finance ↗

See more from November 18, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.